Skip to main content
logo
Curis Lifesciences Limited (NSE:CURIS)
India flag India · Delayed Price · Currency is INR
207.00
0.00 (0.00%)
At close: Oct 5, 2026

Curis Lifesciences Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
606.29606.29502.59355.56354.49237.45
Revenue Growth
155.33%20.63%41.35%0.30%49.29%11.69%
Gross Profit
186.29186.29183.02124.3170.5379.63
Operating Income
104.34104.34100.6977.1131.828.26
Net Income
68.8168.8162.0648.6718.754.92
Earnings Per Share
37.1437.1433.508.263.180.90
EPS Growth
4048.11%10.87%305.70%159.53%255.33%-3.17%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
131.65131.653.044.181.521.11
Total Debt
215.91215.91156.18170.89161.93176.24
Net Cash (Debt)
-84.26-84.26-153.14-166.72-160.41-175.13
Net Cash Growth
------
Net Cash Per Share
-45.47-45.47-82.65-28.28-27.21-31.84

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-164.16-164.16-20.322.833.5549.46
Capital Expenditures
-18.02-18.02-0.93-0.73-6.23-3.99
Free Cash Flow
-182.18-182.18-21.252.0727.3145.47
Free Cash Flow Growth
----92.42%-39.93%-

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
30.73%30.73%36.42%34.96%19.90%33.53%
Operating Margin
17.21%17.21%20.04%21.69%8.97%11.90%
Pretax Margin
15.77%15.77%17.88%20.17%6.18%5.17%
Profit Margin
11.35%11.35%12.35%13.69%5.29%2.07%
FCF Margin
-30.05%-30.05%-4.23%0.58%7.70%19.15%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
5.4410.92----
PS Ratio
2.691.24----